Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
January 1, 2017
December 30, 2016
December 29, 2016
December 28, 2016
December 26, 2016
December 22, 2016
December 19, 2016
December 15, 2016
December 12, 2016
December 8, 2016
December 8, 2016
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community